Spread the word. Share the Gastric Cancer Foundation Newsletter.
Your Participation in the Registry Can Directly Support New Gastric Cancer Research
The Gastric Cancer Registry team has announced a partnership with Dr. Robert Huang and Dr. Joo Ha Hwang of the Stanford Gastric Intestinal Metaplasia Cohort to investigate the genetic and other drivers of stomach cancer. Through this collaboration, researchers are actively seeking a better understanding genetic and other drivers of gastric cancer and potential methods for large-scale early detection and prevention.

Your participation can be of enormous value in research studies like this one. If you or your family has been touched by gastric cancer, we urge you to connect with the Gastric Cancer Registry now. 
YOU ARE ELIGIBLE TO ENROLL IF YOU HAVE ONE OF THE FOLLOWING: 
You have been diagnosed with gastric cancer.
You have a family history of gastric cancer in a first or second degree relative.
You have a known germline mutation of your CDH1 gene.
Enrollment involves an online questionnaire and donation of a small saliva sample. You will be asked for a tissue sample if you had surgery to remove part or all of your stomach. Staff is available to answer your questions and assist with the enrollment process. Visit gcregistry.stanford.edu or call (650) 497-3619.

The Gastric Cancer Registry was launched in 2011 by the Gastric Cancer Foundation with the generosity of Diane and Ronald Weintraub, in memory of their beloved daughter Beth Weintraub Schoenfeld.
Hope on the Horizon
Jason Bosinoff is approaching the half-way mark in his amazing 650-mile solo hike along the Pacific Coast Trail. He has encouraged people to show their support by making contributions to a cause that is important to his family – finding a cure for gastric cancer.

While we can’t join Jason out on the trail, everyone can still be part of his challenge and cheer him on as he heads toward the finish line. Please support Jason – and gastric cancer research – by donating to Gastric Cancer Foundation through Jason’s special fundraising page. In early April, Jason asked us to pass along this personal message:

Thank you so much for your support of the Gastric Cancer Foundation. Your support means a lot and goes a long way. It has been an honor to raise funds and awareness through my hike! I’m 198 miles through my 652 mile journey.

We wish Jason a safe and satisfying second half of his journey.  Visit Jason's blog to view his full journal and photos from the trail.  Follow us on Facebook  as we share updates as Jason moves along the trail.
Smart Patients Offers Online Support for Patients and Caregivers
Gastric Cancer Foundation and Smart Patients have joined together to create a safe and supportive online community – exclusively for patients and caregivers. This community is an easily accessible place to share experiences, questions, information and support with others who are facing similar challenges. 

One participating caregiver has this to say about their experience with Smart Patients:

"The valuable information I have gained from the Smart Patients site regarding gastric cancer came from a member who sent links to journal articles very shortly after I posed a question about immunotherapy. Those scholarly resources and the quick response I received were immensely helpful. Someone had my back, I felt, and they understood what it is to be in the caregiver's role when top-quality responses and information desperately are needed.

In the local community where my partner and I live there are no gastric cancer supports beyond the oncology team per se, and just knowing of the Gastric Cancer Foundation immediately gave me connection to a reliable, dedicated resource. One goal I am holding is to be a personal resource of information for other families enduring this illness."

Research Roundup
There has been a lot of exciting news in gastric cancer research over the last few months. Here are a few highlights:

The U.S. Food and Drug Administration approved Taiho Oncology’s LONSURF® (trifluridine/tipiracil) for adult patients with previously treated advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma, based on a phase 3 trial showing the drug prolonged overall survival.

The gene gastrokine 1 (GKN1) has been linked to gastric cancer, and it could be a target for diagnostics and drug development.

A study in JAMA shows patients with stage I gastric cancer who undergo laparoscopic distal gastrectomy have long-term survival rates similar to those who have open distal gastrectomy.
Spring Back to a Familiar Recipe
The warm and bright flavors of this kale salad are welcomed back this Spring! Board member and "Chef Without A Stomach," Hans Rueffert, brings you delicious and nutrient-rich food for healing through any season. Find this recipe and others at the Gesundheit Kitchen on gastriccancer.org.
Special Thanks to Our
National Sustaining Sponsors
We are honored to welcome Taiho Oncology as our newest national sponsor! National sponsors provide essential support for Gastric Cancer Foundation programs and services.